Completed NA INTERVENTIONAL 1-arm NCT02349555

Nutritional Supplement Impact on Metabolic Parameters

An Open-Label Single-Center Study to Determine Safety and Effects of Novel Nutritional Blend on Inflammatory Balance Markers and Metabolic Parameters

Sponsor: Pharmanex

Conditions Other Endocrine/Nutritional/Metabolic Disorder

Interventions Nutritional Supplement Blend

Updated 5 times since 2017 Last updated: Sep 26, 2016 Started: Jan 31, 2015 Primary completion: Aug 31, 2016 Completion: Aug 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Other Endocrine/Nutritional/Metabolic Disorder and is currently completed. Pharmanex leads this study, which shows 5 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pharmanex
Texas Diabetes & Endocrinology, P.A.
Utah State University

Data source: Pharmanex

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Austin, United States
• Logan, United States